“I am seeing this process rapidly expand, particularly with the use of the single-port robot, which offers additional benefits to things like pain control and helps to further expedite early discharge,” Andrew Wood, MD.
In this video, Andrew Wood, MD, discusses the rollout of a same-day discharge protocol after robot-assisted partial nephrectomy. Wood was first author of the recent Journal of Endourology study, “Same-Day Discharge After Robot-Assisted Partial Nephrectomy: Is It Worth It?” Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at Cleveland Clinic in Cleveland, Ohio.
At Maimonides Medical Center, the practice has rapidly expanded into essentially all providers providing partial nephrectomy and all affiliated individuals, including the postanesthesia care unit [PACU], the nursing staff, and the residents, continue to make improvements on the process. [This includes] things like the PACU nursing team understanding the pace at which patients need to progress to the milestones before they can be discharged and residents and physicians performing early postoperative checks to allow for patients to make their way through the postoperative protocol and be ready for discharge in an expeditious manner. And then additionally, as a fellow at Cleveland Clinic, I am seeing this process rapidly expand, particularly with the use of the single-port robot, which offers additional benefits to things like pain control and helps to further expedite early discharge.
This transcript was edited for clarity.
Toripalimab plus axitinib approved in China for renal cell carcinoma
April 11th 2024The approval is based on findings from the phase 3 RENOTORCH trial, which showed that toripalimab plus axitinib prolonged progression-free survival and improved the objective response rate in patients with advanced RCC compared with sunitinib.